Schedule 13D ownership disclosure
SOLID BIOSCIENCES INC COM NEW
Common Stock, $0.001 par value per share · CUSIP: 83422E105
Event date: 2026-03-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BCLS SB Investco, LPReported CIK 0001728056
Shares: 0 · Class: 0%
- Bain Capital Life Sciences Fund II, L.P.Reported CIK 0001773187
Shares: 267,257 · Class: 0.3%
- BCLS II Investco, LPReported CIK 0001818893
Shares: 8,604,852 · Class: 8.8%
- BCIP Life Sciences Associates, LPReported CIK 0001702921
Shares: 32,550 · Class: 0.1%
- BCLS II Equity Opportunities, LPReported CIK 0001814474
Shares: 904,160 · Class: 1.0%
- Bain Capital Life Sciences Opportunities IV, L.P.Reported CIK 0002015553
Shares: 5,302,897 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-100348
- Form type
- SCHEDULE 13D/A
- Filer
- BCLS SB Investco, LP
- CIK
- CIK 1728056
- Filed
- Mar 10, 2026
- Reporting period
- Mar 06, 2026
- Description
- Schedule 13D beneficial ownership